A Novel Modified Bu/Vp16/cy/Flu/Ara-C Conditioning Regimen Enhances Outcomes for High-Risk Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Puntos clave
To evaluate the effectiveness of a new conditioning regimen for improving outcomes in high-risk acute lymphoblastic leukemia patients undergoing transplant.
Utilized a modified conditioning regimen including Bu/Cy/Vp16/Flu/Ara-C.
Focused on high-risk acute lymphoblastic leukemia patients in complete remission 1 (CR1).
Evaluated patient prognosis post-transplantation.
Significant enhancement in patient prognosis observed.
Improved transplant outcomes noted especially in patients categorized as high-risk during CR1.
Resumen
The novel modified Bu/Cy/Vp16/Flu/Ara-C conditioning significantly enhances the prognosis of high-risk ALL patients receiving transplantation, especially those in CR1.